financetom
Business
financetom
/
Business
/
Looking At Viking Therapeutics's Recent Unusual Options Activity
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Looking At Viking Therapeutics's Recent Unusual Options Activity
Jun 6, 2024 11:36 AM

Whales with a lot of money to spend have taken a noticeably bearish stance on Viking Therapeutics ( VKTX ).

Looking at options history for Viking Therapeutics ( VKTX ) we detected 19 trades.

If we consider the specifics of each trade, it is accurate to state that 15% of the investors opened trades with bullish expectations and 63% with bearish.

From the overall spotted trades, 6 are puts, for a total amount of $251,830 and 13, calls, for a total amount of $1,126,334.

Projected Price Targets

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $30.0 to $100.0 for Viking Therapeutics ( VKTX ) during the past quarter.

Insights into Volume & Open Interest

Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Viking Therapeutics's ( VKTX ) options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Viking Therapeutics's ( VKTX ) whale trades within a strike price range from $30.0 to $100.0 in the last 30 days.

Viking Therapeutics Option Activity Analysis: Last 30 Days

Biggest Options Spotted:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume
VKTX CALL TRADE NEUTRAL 07/19/24 $10.5 $9.4 $10.0 $50.00 $330.0K 663 0
VKTX CALL TRADE BEARISH 07/19/24 $6.4 $6.0 $6.0 $60.00 $180.0K 1.3K 329
VKTX CALL SWEEP BULLISH 01/17/25 $15.4 $14.6 $15.3 $60.00 $148.2K 288 128
VKTX CALL TRADE BEARISH 01/17/25 $31.0 $30.5 $30.5 $30.00 $103.7K 1.5K 34
VKTX PUT SWEEP BEARISH 11/15/24 $7.1 $5.3 $5.4 $40.00 $86.4K 175 161

About Viking Therapeutics

Viking Therapeutics Inc ( VKTX ) is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Current Position of Viking Therapeutics

Trading volume stands at 2,392,518, with VKTX's price down by -4.62%, positioned at $56.16.

RSI indicators show the stock to be may be oversold.

Earnings announcement expected in 48 days.

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Viking Therapeutics ( VKTX ) with Benzinga Pro for real-time alerts.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AI-driven drug discovery picks up as FDA pushes to reduce animal testing
AI-driven drug discovery picks up as FDA pushes to reduce animal testing
Sep 2, 2025
By Sneha S K and Puyaan Singh Sept 2 (Reuters) - Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results, in line with an FDA push to reduce animal testing in the near future. Within the next three to five years, using AI and cutting back on animal testing could...
K Wave Media to Acquire 55% Stake in South Korea-Based 3D Visual Content Studio
K Wave Media to Acquire 55% Stake in South Korea-Based 3D Visual Content Studio
Sep 2, 2025
08:45 AM EDT, 09/02/2025 (MT Newswires) -- K Wave Media ( KWM ) said Tuesday that it will acquire a 55% stake in South Korea-Based 3D visual content studio Rabbit Walk by issuing 9 billion South Korean won ($6.4 million) in shares. The company said it will issue an additional 9 billion won of equity if Rabbit Walk achieves over...
DynaCERT Receives Purchase Order From Hydrofuel For 100 HydraGEN Units
DynaCERT Receives Purchase Order From Hydrofuel For 100 HydraGEN Units
Sep 2, 2025
09:14 AM EDT, 09/02/2025 (MT Newswires) -- dynaCERT (DYA.TO), at the low end of its 52 week trading range, on Tuesday said it has received a purchase order for 100 HS1 HydraGEN units from Hydrofuel Technologies. A deposit has already been paid. Twenty-five units are currently being shipped to Hydrofuel. The 100 units are destined for Mexico, a statement said....
PyroGenesis Signs C$1.2 Million Energy Transition Contract with Cement Industry Customer
PyroGenesis Signs C$1.2 Million Energy Transition Contract with Cement Industry Customer
Sep 2, 2025
08:45 AM EDT, 09/02/2025 (MT Newswires) -- PyroGenesis ( PYRGF ) , which rose more than 5% from near 52 week lows last Friday, on Tuesday said it has signed a C$1.2 million contract with an unidentified European cement industry customer for the supply of a plasma torch system for a calcination furnace. A statement noted the system will be...
Copyright 2023-2026 - www.financetom.com All Rights Reserved